Evidence map›Paper›PMID 37057690›Full record

ArticleHuman vaccines & immunotherapeutics2023

A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac-ChAdOx1.

Saipin Pongsatha, Theera Tongsong, Jiraprapa Wipasa, Supachai Sakkhachornphop, Sayamon Hongjaisee, Kriangkrai Chawansuntati

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Saipin PongsathaDepartment of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Theera TongsongDepartment of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Jiraprapa WipasaResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Supachai SakkhachornphopResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Sayamon HongjaiseeResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Kriangkrai ChawansuntatiResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Chiang Mai University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective is to evaluate the effectiveness of placental transfer of maternally derived SARS-CoV-2 IgG antibodies after the vaccination of pregnant women with heterologous CoronaVac-ChAdOx1. Thirty pregnant women were vaccinated with CoronaVac as the first dose, followed by ChAdOx1 3 weeks later. The antibody levels in the maternal blood and in the umbilical cord blood at the time of delivery were determined. The results showed that the vaccination effectively increased antibody levels in both mothers and newborns. The antibody levels in the mothers were strongly correlated with those in the newborns (

Indexed as

COVID-19Pregnancy Complications, InfectiousAntibodies, ViralChAdOx1 nCoV-19COVID-19 VaccinesFemaleHumansInfant, NewbornPlacentaPregnancySARS-CoV-2Vaccines, InactivatedAntibodies, ViralChAdOx1 nCoV-19COVID-19 Vaccinessinovac COVID-19 vaccineVaccines, InactivatedAdenoviral vectorantibodiesCOVID-19heterologous prime-boostimmunogenicityinactivatednewbornpregnancySARS-CoV-2spike proteinvaccine

Identifiers

PMID37057690
PMCPMC10116919
OpenAlexW4365478823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.